Article Details

Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to ...

Retrieved on: 2021-01-19 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to .... View article details on HISWAI: https://www.globenewswire.com/news-release/2021/01/19/2160284/0/en/Consortium-including-ElsaLys-Biotech-and-Novadiscovery-awarded-3-35-million-by-Bpifrance-to-advance-inolimomab-in-graft-versus-host-disease.html

Excerpt

NOVA is a leading health tech company using in silico proprietary technology to optimize clinical trial development and predict drug efficacy. NOVA ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up